Efficacy of oral physostigmine in primar
β
Suha A. Beller; John E. Overall; Alan C. Swann
π
Article
π
1985
π
Springer
π
English
β 525 KB
To examine the efficacy of cholinergic enhancement in senile dementia of the Alzheimer type (SDAT), oral physostigmine was given to eight patients in a cross-over trial of three dose levels and a matching placebo. A dose-related improvement in memory as measured by objective verbal memory tests was